Regression of coronary atherosclerotic lesions after rHDL infusions in acute coronary syndrome patients as assessed by intravascular ultrasound
Phase of Trial: Phase II
Latest Information Update: 29 Mar 2007
At a glance
- Drugs CSL 111 (Primary)
- Indications Acute coronary syndromes; Atherosclerosis
- Focus Therapeutic Use
- Acronyms ERASE
- Sponsors CSL
- 29 Mar 2007 Status change
- 26 Mar 2007 Results data have been published.
- 01 Mar 2007 New trial record.